Stemming the growth of pediatric gliomas through histone modification
- 20 January 2021
- journal article
- editorial
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 23 (3) , 341-342
Abstract
A surprising theme that has emerged from sequencing the cancer genome is that mutations in genes encoding histone proteins are very common. Histones bind DNA to form bead-like structures (nucleosomes) along the DNA strand. At each nucleosome, the DNA double helix wraps around a complex of four pairs of core histone proteins (H2A, H2B, H3, and H4), spanned by a single linker protein (H1). Histones are no longer considered to be simply DNA-packaging proteins but instead are understood to be dynamic regulators of gene expression.1 Covalent modifications of histones, such as addition and removal of methyl and acetyl groups on lysine residues, induce conformational...Keywords
This publication has 9 references indexed in Scilit:
- Optimal therapeutic targeting by HDAC inhibition in biopsy-derived treatment-naïve diffuse midline glioma modelsNeuro-Oncology, 2021
- Diffuse midline glioma: review of epigeneticsJournal of Neuro-Oncology, 2020
- Contemporary survival endpoints: an International Diffuse Intrinsic Pontine Glioma Registry studyNeuro-Oncology, 2017
- Functionally defined therapeutic targets in diffuse intrinsic pontine gliomaNature Medicine, 2015
- Erasers of Histone Acetylation: The Histone Deacetylase EnzymesCold Spring Harbor Perspectives in Biology, 2014
- Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastomaNature, 2012
- Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomasNature Genetics, 2012
- Histone onco-modificationsOncogene, 2011
- Histone and chromatin cross-talkCurrent Opinion in Cell Biology, 2003